| Issuer | % of Class | Filed |
|---|---|---|
|
Amneal Pharmaceuticals, Inc.
13D/A
Amendment 5
AMRX · 03168L105
|
9.4% |
8/12/2026
Event 8/10/2026
|
|
Amneal Pharmaceuticals, Inc.
13D/A
Amendment 4
AMRX · 03168L105
|
8.2% |
10/7/2025
Event 10/3/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.